摘要
目的探究濒死期路径干预在胃癌患者中的效果.方法选取2013-06/2016-06天津医科大学第二医院收治的96例濒死期胃癌患者为研究对象,采用随机数表法将96例患者分为对照组和观察组,各48例.给予对照组患者常规临终干预,给予观察组患者濒死期路径干预.比较2组患者的症状控制情况、护理质量评分、生存时间、汉密顿抑郁量表(Hamilton Depression Scale,HAMD)评分.结果观察组患者呼吸困难、疼痛、恶心呕吐的控制情况均显著优于对照组患者,差异具有统计学意义(P<0.05).2组患者的生存时.间差异不具有统计学意义(P>0.05);观察组患者的护理质量评分显著高于对照组患者,差异具有统计学意义(P<0.05).干预前2组患者的HAMD评分差异不具有统计学意义.(P>0.05);干预后4 wk观察组患者的HAMD评分显著低于对照组患者,差异具有统计学意义(P<0.05).结论给予濒死期胃癌患者濒死期路径干预较常规干预能够显著改善其临床症状,改善患者抑郁情绪,提高临终生存质量.
AIM To explore the effect of pathway intervention in agonal patients with gastric cancer.METHODS Ninety-six agonal patients with gastric cancer treated from June 2013 to June 2016 at our hospital were randomly divided into either a control group or an observation group,with48 cases in each group.The control group received conventional palliative intervention,and the observation group was given pathway intervention.Symptom control,nursing quality score,survival time,and Hamilton Depression Scale（HAMD） score were compared between the two groups.RESULTS The control of dyspnea,pain,nausea and vomiting in the observation group was significantly better than that in the control group（P〈0.05）.The difference in survival time between the two groups was not statistically significant（P〉0.05）.Nursing quality score was significantly higher in the observation group than in the control group（P〈0.05）.HAMD score before intervention did not differ significantly between the two groups（P〉0.05）,but was significantly lower in the observation group than in the control group after 4 wk of intervention（P〈0.05）.CONCLUSION Pathway intervention in agonal gastric cancer patients can significantly improve clinical symptoms,depression,and quality of life.
出处
《世界华人消化杂志》
CAS
2017年第4期383-387,共5页
World Chinese Journal of Digestology
关键词
濒死期
路径干预
胃肠
癌症
Agonal
Pathway intervention
Gastrointestinal
Cancer
